Johnson & Johnson
(NYSE:JNJ)
$
259.33
-3.71 (-1.41%)
Market Cap: 624.26 Bil
Enterprise Value: 657.20 Bil
PE Ratio: 29.98
PB Ratio: 7.69
GF Score: 81/100 Johnson & Johnson at Cowen Health Care Conference Transcript
Mar 07, 2023 / 04:10PM GMT
Release Date Price:
$154.09
(-0.94%)
Joshua Thomas Jennings
TD Cowen, Research Division - MD & Senior Research Analyst
Okay. Good morning. I'm Josh Jennings, Cowen Medical Devices team. We're moving right through the medical devices track, but we are incorporating some medical device part of a consumer hybrid into this track. And thankfully, with the executive team from Johnson & Johnson, we have Executive Vice President and Chief Financial Officer, Joe Wolk; and Vice President of Investor Relations, Jessica Moore. Joe, Jessica. Josh, we got 3 Js up here. Can't lose. Can't lose.
Thank you guys for participating in Cowen Healthcare -- TD Cowen Healthcare Conference, and great to see you in person.
Joseph J. Wolk
Johnson & Johnson - Executive VP & CFO
Same here. Thanks, Josh, for having us.
Questions & Answers
Joshua Thomas Jennings
TD Cowen, Research Division - MD & Senior Research Analyst
Maybe to start, I just wanted to talk about some of the headwinds. I know Johnson & Johnson reports first, at least in
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot